日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Balloon pericardiotomy for malignant pericardial effusion: the PMAP trial

球囊心包切开术治疗恶性心包积液:PMAP试验

Yan, Bryan Ping-Yen; Kam, Kevin Ka-Ho; Lai, Angel; Ng, Canice Lok-Hang; Chan, Ngai-Yin; Chan, Lap-Shing; Wong, Chi-Wing; Yam, Ping-Wa; Chi, Wai-Kin; Chan, Stephen Lam; Wong, Randolph Hung Leung; Wu, Eugene Brian; Chan, Joseph Yat-Sun; Lee, Alex Pui-Wai; Tan, Guang-Ming

Impact of Age on Patient-Reported Outcomes with First-Line Camrelizumab plus Rivoceranib versus Sorafenib in Adults with Unresectable Hepatocellular Carcinoma: Post Hoc Analyses of the CARES-310 Open-Label, Randomized, Phase 3 Trial

年龄对不可切除肝细胞癌成人患者一线卡瑞利珠单抗联合利沃西拉尼与索拉非尼单药治疗患者报告结局的影响:CARES-310开放标签、随机、3期试验的事后分析

Chan, Stephen Lam; Kaseb, Ahmed Omar; Alexander, Laura; Meng, Xianzhang; Ryan, Kristin; Shi, Wei; Vogel, Arndt

Prognostic implications of tumour number in intrahepatic cholangiocarcinoma

肝内胆管癌中肿瘤数量的预后意义

Chan, Brandon Lok-Hang; Li, Yan; Kim, YoungJae; Wong, Alex Chi-Fung; Yiu, Dorothy Cheuk-Yan; Chan, Landon Long; Chu, Cheuk Man; Yoo, Changhoon; Sun, Hui-Chuan; Chan, Stephen Lam

Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer

接受免疫检查点抑制剂或酪氨酸激酶抑制剂治疗肝癌患者乙型肝炎病毒再激活的比较风险

Yiu, Dorothy Cheuk-Yan; Lai, Jimmy Che-To; Chan, Landon Long; Wong, Grace Lai-Hung; Lai, Mandy Sze-Man; Wong, Vincent Wai-Sun; Tse, Yee-Kit; Chan, Henry Lik-Yuen; Chan, Stephen Lam; Yip, Terry Cheuk-Fung

Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma

STAT1-GSDME 细胞焦亡通路药理学激活可增强肝细胞癌的表观遗传免疫疗法。

Tu, Yalin; Wu, Haoran; Zhong, Chengpeng; Liu, Yan; Xiong, Zhewen; Chen, Siyun; Wang, Jing; Wong, Patrick Pak-Chun; Yang, Weiqin; Liang, Zhixian; Lu, Jiahuan; Chen, Shufen; Zhang, Lingyun; Feng, Yu; Si-Tou, Willis Wai-Yiu; Yin, Baoyi; Lin, Yingnan; Liang, Jianxin; Liang, Liying; Vong, Joaquim S L; Ren, Weida; Kwong, Tsz Tung; Leung, Howard; To, Ka Fai; Ma, Stephanie; Tong, Man; Sun, Hanyong; Xia, Qiang; Zhou, Jingying; Kerr, David; La Thangue, Nick; Sung, Joseph J Y; Chan, Stephen Lam; Cheng, Alfred Sze-Lok

Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma

野生型KRAS激活驱动肝细胞癌逃避干扰素介导的免疫反应并产生免疫治疗耐药性。

Martina Mang Leng Lei ,Carmen Oi Ning Leung ,Rainbow Wing Hei Leung ,Xue Qian Wu ,Katherine Po Sin Chung ,Catherine Yu Jia Gu ,Mandy Sze Man Chan ,Wing Ki Chau ,Quan Hua Mu ,Kai Yu Ng ,Man Tong ,Jing Ping Yun ,Jia Ming Nickolas Teo ,Guang Sheng Ling ,Patrick Pak Chun Wong ,Stephen Lam Chan ,Zhe Wen Xiong ,Alfred Sze Lok Cheng ,Jin Ding ,Stephanie Ma ,Terence Kin Wah Lee

Overcoming immunotherapy resistance in hepatocellular carcinoma by targeting myeloid IL-8/CXCR2 signaling

通过靶向髓系IL-8/CXCR2信号通路克服肝细胞癌的免疫治疗耐药性

Kwong, Tsz Tung; Xiong, Zhewen; Zhang, Yiling; Wu, Haoran; Cao, Jianquan; Pak-Chun Wong, Patrick; Liu, Xiaoyu; Wang, Jing; Wong, Chi Hang; Man-Kit Tse, Gary; Jao-Yiu Sung, Joseph; Zhou, Jingying; Sze-Lok Cheng, Alfred; Chan, Stephen Lam

Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus Bevacizumab

一项多中心 II 期试验,评估瑞戈非尼二线治疗在接受阿特珠单抗联合贝伐珠单抗治疗后进展的不可切除肝细胞癌患者的疗效

Cheon, Jaekyung; Ryoo, Baek-Yeol; Chon, Hong Jae; Kim, Hyung-Don; Ryu, Min-Hee; Kim, Kyu-Pyo; Kang, Beodeul; Finn, Richard S; Chan, Stephen Lam; Yoo, Changhoon

Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis

Durvalumab 和 Tremelimumab 作为一线治疗方案用于不可切除且预后不良的肝细胞癌患者的 3b 期 SIERRA 研究的早期安全性结果

Chan, Stephen Lam; Kudo, Masatoshi; Sangro, Bruno; Kelley, Robin Kate; Kim, Jee Hyun; Pham, Binh; Hong, Jung Yong; Waldschmidt, Dirk-Thomas; Marino, Donatella; Joycelyn Lee, Jie Xin; Gerolami, René; Burgoyne, Adam M; Li, Qiao; Nakamura, Hitomi; Sun, Peng; Baur, Boris; Rimassa, Lorenza

Patient-derived organoids inform pharmacogenomic vulnerabilities in liver cancer

患者来源的类器官揭示肝癌的药物基因组学脆弱性

Wong, Alissa Michelle; Huang, Hao; Wong, Aikha Melissa; Leung, Howard Ho Wai; Cheung, Winnie Wing Yan; Lam, Yin Kau; Ding, Xiaofan; Zhang, Luyao; Chu, Clarice; Liu, Yue; Chan, Cecilia Ka Wing; Chan, Anthony Wing Hung; Ng, Kelvin Kwok Chai; Wang, Xin; Chan, Stephen Lam; Wong, Nathalie